Total Payments
$4,343
2024 Payments
$1,082
Companies
28
Transactions
184
Medicare Patients
2,946
Medicare Billing
$166,499
Payment Breakdown by Category
Food & Beverage$3,782 (87.1%)
Education$560.90 (12.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,782 | 177 | 87.1% |
| Education | $560.90 | 7 | 12.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,052 | 39 | $0 (2024) |
| Boston Scientific Corporation | $815.02 | 26 | $0 (2024) |
| Amgen Inc. | $410.37 | 22 | $0 (2024) |
| Medtronic, Inc. | $329.45 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $304.03 | 19 | $0 (2024) |
| PFIZER INC. | $143.21 | 6 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $140.11 | 6 | $0 (2024) |
| Amarin Pharma Inc. | $125.48 | 1 | $0 (2019) |
| Medtronic Vascular, Inc. | $121.48 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $120.44 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,082 | 53 | Novartis Pharmaceuticals Corporation ($144.23) |
| 2023 | $744.74 | 40 | AstraZeneca Pharmaceuticals LP ($202.17) |
| 2022 | $629.04 | 35 | Medtronic, Inc. ($126.54) |
| 2021 | $239.45 | 10 | AstraZeneca Pharmaceuticals LP ($165.61) |
| 2020 | $235.98 | 6 | AstraZeneca Pharmaceuticals LP ($106.40) |
| 2019 | $808.82 | 28 | AstraZeneca Pharmaceuticals LP ($272.05) |
| 2018 | $504.41 | 11 | BOSTON SCIENTIFIC CORPORATION ($163.04) |
| 2017 | $99.00 | 1 | AstraZeneca Pharmaceuticals LP ($99.00) |
All Payment Transactions
184 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: EndoVenous Therapies | ||||||
| 12/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $55.26 | General |
| 12/06/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $38.95 | General |
| 11/26/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/22/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $25.63 | General |
| Category: Coronary | ||||||
| 11/21/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $45.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: EndoVenous Therapies | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $17.58 | General |
| 11/11/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Not Applicable | ||||||
| 11/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Cardiology | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Obesity | ||||||
| 10/25/2024 | AltaThera Pharmaceuticals LLC | Sotalol Hydrochloride (Drug) | Food and Beverage | Cash or cash equivalent | $14.38 | General |
| Category: Cardiovascular | ||||||
| 10/21/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $33.71 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/21/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Cardiology | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.99 | General |
| Category: Cardiovascular | ||||||
| 09/18/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/30/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $20.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,424 | 1,581 | $258,184 | $81,230 |
| 2022 | 23 | 1,105 | 1,253 | $198,735 | $63,348 |
| 2021 | 13 | 417 | 436 | $64,932 | $21,921 |
Total Patients
2,946
Total Services
3,270
Medicare Billing
$166,499
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 252 | 316 | $89,844 | $27,182 | 30.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 250 | 252 | $38,687 | $11,728 | 30.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 74 | 127 | $22,713 | $7,809 | 34.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 70 | 71 | $20,903 | $7,180 | 34.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $17,789 | $5,631 | 31.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 29 | $11,372 | $3,654 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 22 | 25 | $5,494 | $1,757 | 32.0% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 20 | 21 | $5,014 | $1,740 | 34.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 32 | 32 | $5,479 | $1,724 | 31.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 155 | 163 | $5,216 | $1,670 | 32.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 14 | $5,592 | $1,650 | 29.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 18 | $4,843 | $1,587 | 32.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 32 | 32 | $4,913 | $1,558 | 31.7% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 27 | 27 | $4,145 | $1,288 | 31.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 17 | 20 | $2,977 | $876.67 | 29.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 116 | 130 | $2,387 | $791.16 | 33.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 63 | 63 | $1,974 | $598.95 | 30.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 17 | 17 | $1,474 | $511.87 | 34.7% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Facility | 2023 | 27 | 28 | $1,600 | $495.75 | 31.0% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2023 | 21 | 21 | $1,580 | $437.73 | 27.7% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 21 | 22 | $1,228 | $387.20 | 31.5% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Facility | 2023 | 15 | 15 | $814.95 | $245.18 | 30.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 39 | 39 | $716.04 | $229.32 | 32.0% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 16 | 16 | $635.52 | $220.80 | 34.7% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 11 | 11 | $628.54 | $218.13 | 34.7% |
About Elston Johnson
Elston Johnson is a Cardiovascular Disease healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2015. The National Provider Identifier (NPI) number assigned to this provider is 1568854065.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Elston Johnson has received a total of $4,343 in payments from pharmaceutical and medical device companies, with $1,082 received in 2024. These payments were reported across 184 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($3,782).
As a Medicare-enrolled provider, Johnson has provided services to 2,946 Medicare beneficiaries, totaling 3,270 services with total Medicare billing of $166,499. Data is available for 3 years (2021–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Columbus, OH
- Active Since 02/21/2015
- Last Updated 07/26/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1568854065
Products in Payments
- BRILINTA (Drug) $515.27
- Repatha (Biological) $289.67
- FARXIGA (Drug) $269.87
- VENASEAL (Device) $202.36
- ENTRESTO (Drug) $171.40
- EMBLEM (Device) $166.37
- VYNDAQEL (Drug) $143.21
- WATCHMAN (Device) $134.23
- LEQVIO (Drug) $132.63
- Vascepa (Drug) $125.48
- CoreValve Evolut (Device) $121.48
- XARELTO (Drug) $120.44
- WATCHMAN Access System (Device) $120.22
- WATCHMAN FLX (Device) $107.32
- RESONATE (Device) $90.25
- VERQUVO (Drug) $89.04
- Corlanor (Drug) $76.34
- CLOSUREFAST (Device) $72.38
- ELIQUIS (Drug) $71.62
- Impella (Device) $68.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Columbus
Gary Ansel, Md, MD
Cardiovascular Disease — Payments: $4.6M
Cardiovascular Disease $4.6M
Hunter Champion, M.d, M.D
Cardiovascular Disease — Payments: $1.7M
Cardiovascular Disease $1.7M
Steven Yakubov, Md, MD
Cardiovascular Disease — Payments: $1.2M
Cardiovascular Disease $1.2M
Mitchell Silver, Do, DO
Cardiovascular Disease — Payments: $781,405
Cardiovascular Disease $781,405
Rami Kahwash, M.d, M.D
Cardiovascular Disease — Payments: $425,557
Cardiovascular Disease $425,557
John Phillips, M.d, M.D
Cardiovascular Disease — Payments: $395,324
Cardiovascular Disease $395,324